E for L Aim Public Company Limited
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand. The company offers clinical hematology, microscopy, chemistry, immunology, and microbiology related products. It also provides various equipment for medical devices. In addition, the company offers educational, clinical and laboratory microscopes, and scien… Read more
Market Cap & Net Worth: E for L Aim Public Company Limited (EFORL)
E for L Aim Public Company Limited (BK:EFORL) has a market capitalization of $16.14 Million (฿559.79 Million) as of March 19, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #27215 globally and #461 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying E for L Aim Public Company Limited's stock price ฿0.14 by its total outstanding shares 3998477368 (4.00 Billion).
E for L Aim Public Company Limited Market Cap History: 2015 to 2026
E for L Aim Public Company Limited's market capitalization history from 2015 to 2026. Data shows change from $861.00 Million to $16.14 Million (-34.42% CAGR).
E for L Aim Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how E for L Aim Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
E for L Aim Public Company Limited's market cap is 0.02 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.58x
E for L Aim Public Company Limited's market cap is 1.58 times its annual earnings
9.21x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $861.00 Million | $4.50 Billion | $210.39 Million | 0.19x | 4.09x |
| 2016 | $311.34 Million | $3.67 Billion | -$614.45 Million | 0.08x | N/A |
| 2017 | $80.72 Million | $2.47 Billion | -$1.16 Billion | 0.03x | N/A |
| 2018 | $69.19 Million | $2.06 Billion | -$166.31 Million | 0.03x | N/A |
| 2019 | $46.12 Million | $1.92 Billion | -$590.58 Million | 0.02x | N/A |
| 2020 | $69.19 Million | $1.67 Billion | -$633.52 Million | 0.04x | N/A |
| 2021 | $230.62 Million | $2.17 Billion | $812.03 Million | 0.11x | 0.28x |
| 2022 | $39.21 Million | $1.49 Billion | $53.04 Million | 0.03x | 0.74x |
| 2023 | $28.83 Million | $1.31 Billion | $13.43 Million | 0.02x | 2.15x |
| 2024 | $31.13 Million | $1.34 Billion | $19.69 Million | 0.02x | 1.58x |
Competitor Companies of EFORL by Market Capitalization
Companies near E for L Aim Public Company Limited in the global market cap rankings as of March 19, 2026.
Key companies related to E for L Aim Public Company Limited by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
E for L Aim Public Company Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, E for L Aim Public Company Limited's market cap moved from $861.00 Million to $ 16.14 Million, with a yearly change of -34.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿16.14 Million | -6.67% |
| 2025 | ฿17.30 Million | -44.44% |
| 2024 | ฿31.13 Million | +8.00% |
| 2023 | ฿28.83 Million | -26.47% |
| 2022 | ฿39.21 Million | -83.00% |
| 2021 | ฿230.62 Million | +233.33% |
| 2020 | ฿69.19 Million | +50.00% |
| 2019 | ฿46.12 Million | -33.33% |
| 2018 | ฿69.19 Million | -14.29% |
| 2017 | ฿80.72 Million | -74.07% |
| 2016 | ฿311.34 Million | -63.84% |
| 2015 | ฿861.00 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of E for L Aim Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.14 Million USD |
| MoneyControl | $16.14 Million USD |
| MarketWatch | $16.14 Million USD |
| marketcap.company | $16.14 Million USD |
| Reuters | $16.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.